InvestorsHub Logo
Followers 65
Posts 23923
Boards Moderated 0
Alias Born 11/23/2016

Re: frrol post# 114198

Sunday, 08/06/2017 9:19:15 PM

Sunday, August 06, 2017 9:19:15 PM

Post# of 462555
Anyone investing in biotech, and in life generally, should allow nagging doubts their rightful place in evaluating and acting on information.

Things are not always as they appear. Many things contested and argued about Anavex certainly forces me to reinterpret my own conclusions.

In executing a biotech investment strategy, I for one consider Anavex one of the current top contenders for a place in my portfolio for risk/reward ratio - sounds to me like it does for you also.

At least for some time now the Anavex critical review has graduated from corner printing shop turned biotech and Nell Rebow's qualities, so things are still moving along.

Meanwhile, I'm prepared for the real possibility that my assessment turns out wrong.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News